Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04126018 · ClinicalTrials.gov registry record
Comparative Imaging Assessment of Valvular Heart Disease
A clinical trial of Aortic Stenosis and Aortic Regurgitation, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04126018: Recruiting study of Aortic Stenosis and Aortic Regurgitation, sponsored by The Cleveland Clinic.
NCT04126018 is a study of Aortic Stenosis and Aortic Regurgitation that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 200 participants, below the 1,355-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04126018, a study of Aortic Stenosis and Aortic Regurgitation, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare the various 2D and 3D methods of valvular heart disease quantification (Doppler, PISA, VCA, volumetric method) and strain with cardiac magnetic resonance (CMR) measurements of left and right ventricular systolic function strain and myocardial fibrosis assessment.
Primary Outcome
10% Change from Baseline - units of measure cc/m2
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Echocardiography
- DIAGNOSTIC_TEST MRI with strain measurement
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-08-23 |
| Est. Completion | 2027-12-31 |
What NCT04126018 shows while recruiting
NCT04126018 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,355-participant average among 26 other Aortic Stenosis trials with a reported enrollment target (85% lower).
The record links to 3 conditions, with Aortic Stenosis appearing as the primary indexed condition, and to 2 interventions - of which Echocardiography is the first listed.
NCT04126018 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04126018 about?
NCT04126018 is a clinical study titled "Comparative Imaging Assessment of Valvular Heart Disease". The purpose of the study is to compare the various 2D and 3D methods of valvular heart disease quantification (Doppler, PISA, VCA, volumetric method) and strain with cardiac magnetic resonance (CMR) measurements of left and right ventricular systolic function strain and myocardial fibrosis assessmen...
What is the current status of trial NCT04126018?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2019-08-23. Estimated completion is 2027-12-31.
What conditions does trial NCT04126018 study?
This clinical trial studies the following conditions: Aortic Stenosis, Aortic Regurgitation, Valve Heart Disease.
What interventions are being tested in trial NCT04126018?
The interventions under investigation include: Echocardiography (DIAGNOSTIC_TEST), MRI with strain measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04126018?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04126018 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04126018's enrollment target sits among peer trials
200 15th of 26 higher than 10 of 26 other Aortic Stenosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Stenosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Loss of Y Chromosome in Aortic Stenosis
RECRUITING
-
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
RECRUITING · Phase 2
-
Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
RECRUITING
-
Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis
RECRUITING · NA
-
Novel Characterization of Sex Specific Biologic Signatures in Valvular Heart Disease
RECRUITING
-
Evaluating Infrasonic Hemodynography
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI